Your browser doesn't support javascript.
loading
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer.
Wu, Yin; Biswas, Dhruva; Usaite, Ieva; Angelova, Mihaela; Boeing, Stefan; Karasaki, Takahiro; Veeriah, Selvaraju; Czyzewska-Khan, Justyna; Morton, Cienne; Joseph, Magdalene; Hessey, Sonya; Reading, James; Georgiou, Andrew; Al-Bakir, Maise; McGranahan, Nicholas; Jamal-Hanjani, Mariam; Hackshaw, Allan; Quezada, Sergio A; Hayday, Adrian C; Swanton, Charles.
Afiliación
  • Wu Y; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. yin.wu@kcl.ac.uk.
  • Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. yin.wu@kcl.ac.uk.
  • Usaite I; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK. yin.wu@kcl.ac.uk.
  • Angelova M; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK. yin.wu@kcl.ac.uk.
  • Boeing S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Veeriah S; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
  • Czyzewska-Khan J; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Morton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Joseph M; Bioinformatics & Biostatistics and Software Development & Machine Learning Team, The Francis Crick Institute, London, UK.
  • Hessey S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Reading J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Georgiou A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Al-Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • McGranahan N; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Jamal-Hanjani M; Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.
  • Hackshaw A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Quezada SA; Cancer Metastasis Lab, University College London Cancer Institute, London, UK.
  • Hayday AC; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
  • Swanton C; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Nat Cancer ; 3(6): 696-709, 2022 06.
Article en En | MEDLINE | ID: mdl-35637401
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido